SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549



                                    FORM 10-Q



[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2005,

                                       OR

[ ]  TRANSITION  REPORT  PURSUANT  TO SECTION  13 OR 15(d) OF THE  SECURITIES
     EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM              TO                 .



Commission file number 1-14120





                        BLONDER TONGUE LABORATORIES, INC.
             (Exact name of registrant as specified in its charter)


           Delaware                               52-1611421  
(State or other jurisdiction                (I.R.S. Employer Identification No.)
of incorporation or organization)

One Jake Brown Road, Old Bridge, New Jersey                       08857
 (Address of principal executive offices)                      (Zip Code)



Registrant's telephone number, including area code:  (732) 679-4000


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

Yes   X    No

Indicate  by check mark  whether  the  registrant  is an  accelerated  filer (as
defined in Rule 12b-2 of the Exchange Act).

Yes       No   X

Number of shares of common stock, par value $.001,  outstanding as of August 12,
2005: 8,015,406.


                      The Exhibit Index appears on page 22.










                         PART I - FINANCIAL INFORMATION



ITEM 1.  FINANCIAL STATEMENTS



               BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS
                                 (In thousands)
                                                  (unaudited)
                                                     June 30,       December 31,
                                                      2005              2004

               Assets (Note 5)
 Current assets:
      Cash..........................................        $25              $70
      Accounts receivable, net of allowance for
          doubtfulaccounts of $520 and $607
          respectively..............................      6,013            3,693
      Inventories (Note 4)..........................      9,169           10,309
      Income tax receivable.........................        330              320
      Prepaid and other current assets..............        587              654
      Deferred income taxes ........................        960              960
                                                         ----------   ----------
          Total current assets......................     17,084           16,006
 Inventories, non-current (net) (Note 4)............      8,135            8,968
 Property, plant and equipment, net of accumulated
     depreciation and amortization .................      6,058            6,214
 Patents, net ......................................      2,051            2,240
 Rights-of-Entry, net (Note 6)......................        850              977
 Other assets, net..................................      1,129              925
 Investment in Blonder Tongue Telephone LLC (Note 6)      1,239            1,430
 Deferred income taxes .............................      1,396            1,396
                                                         ----------   ----------
                                                        $37,942          $38,156
                                                        ===========   ==========
                  Liabilities and Stockholders' Equity
 Current liabilities:
      Current portion of long-term debt (Note 5)..       $6,186           $2,683
      Accounts payable............................        2,023            1,497
      Accrued compensation........................          837              639
      Accrued benefit liability...................          314              314
      Other accrued expenses (Note 8).............          513              270
                                                         ----------    ---------
          Total current liabilities...............        9,873            5,403
                                                         ----------    ---------
 Long-term debt (Note 5)..........................        2,677            5,830
 Commitments and contingencies....................            -                -
 Stockholders' equity:
      Preferred stock, $.001 par value; authorized
          5,000 shares; no shares outstanding.....            -                -
      Common stock, $.001 par value; authorized 25,000
          shares, 8,445 shares Issue..............            8                8
      Paid-in capital.............................       24,202           24,202
      Retained earnings...........................        7,534            9,065
      Accumulated other comprehensive loss........         (897)            (897)
      Treasury stock, at cost, 449 shares.........       (5,455)          (5,455)
                                                        ----------     ---------
          Total stockholders' equity.............        25,392           26,923
                                                        ----------     ---------
                                                        $37,942          $38,156
                                                       ============    =========

          See accompanying notes to consolidated financial statements.



                                       2






               BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                    (In thousands, except per share amounts)
                                   (unaudited)

                          Three Months Ended June 30,  Six Months Ended June 30,
                          ---------------------------  -------------------------
                              2005            2004          2005           2004
                          -----------      ----------- -------------    --------
Net sales................  $ 9,408          $10,917       $18,677        $19,446
Cost of goods sold.......    6,549            7,837        13,291         13,425
                           --------         --------      --------       -------
   Gross profit (Note 7).    2,859            3,080         5,386          6,021
                           --------         ---------      -------       -------
Operating expenses:
   Selling...............    1,124            1,093         2,190          2,138
   General and
     administrative          1,681            1,349         3,334          2,956
   Research and development.   395              391           806            802
                           --------          ---------     --------       ------
                             3,200            2,833         6,330          5,896
                           --------          ---------     --------       ------
Earnings (loss)from
    operations                (341)             247          (944)           125
                           --------          ---------     --------       ------
 Other Expense:
   Interest expense
     (net)...............     (203)            (223)         (396)          (498)
   Interest Income (Note 7).    --              212            --            212
   Equity in loss of Blonder
       Tongue Telephone, LLC...(97)              --          (191)            --
                              ------          ---------     --------      ------
                              (300)             (11)         (587)          (286)
                              ------          ---------     --------      ------
Earnings (loss) before
   income taxes.........      (641)             236        (1,531)          (161)
Provision (benefit)
   for income taxes ....        --               --            --             --
                              ------          ---------     --------      ------
Net (loss) earnings ......... (641)           $ 236        (1,531)        $ (161)
                              ======          =========     ========      ======
Basic earnings(loss) per
    share                  $ (0.08)           $ 0.03        (0.19)        $(0.02)
                             =======          =========     ========      ======
Basic weighted average
    shares outstanding...    8,015             8,002        8,015          7,999
                             -------          ---------     --------      ------
Diluted earnings (loss)
    per share..            $ (0.08)           $ 0.03        (0.19)        $(0.02)
                             =======          ==========    ========      ======

Diluted weighted average
    shares outstanding.      8,015             8,026        8,015          7,999
                             =======          ===========   ========      ======






















          See accompanying notes to consolidated financial statements.



                                       3






          BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 (In thousands)
                                   (unaudited)

                                                       Six Months Ended June 30,
                                                      --------------------------
                                                        2005                2004
                                                       ----------      ---------
 Cash Flows From Operating Activities:
   Net loss.........................................    $(1,531)        $  (161)
   Adjustments to reconcile net (loss) to cash
     provided by (used in) operating activities:
     Depreciation...................................        504             508
     Amortization ..................................        319             418
    Provision for inventory reserves................        879             300
     Equity in loss of Blonder Tongue Telephone, LLC        191              --
  Changes in operating assets and liabilities:
     Accounts receivable............................     (2,320)           (686)
     Inventories....................................      1,094             407
     Prepaid and other current assets...............         67            (220)
     Other assets...................................       (204)              6
     Income taxes...................................        (10)            361
     Accounts payable, accrued compensation
     and other accrued expenses.                            967            (595)
                                                         ------------     ------
       Net cash provided by (used in) operating
          activities.............                           (44)            338
                                                         ------------     ------
Cash Flows From Investing Activities:
   Capital expenditures..................................  (348)           (127)
   Acquisition of rights-of-entry........................    (3)             --
   Collection of note receivable.........................    --             826
                                                         ------------     ------
   Net cash provided by (used in) investing
       activities.....................                      (351)           699
                                                         ------------    -------
 Cash Flows From Financing Activities:
   Borrowings of long-term debt........................... 7,170          6,660
   Repayments of long-term debt...........................(6,820)        (7,674)
   Proceeds from exercise of stock options................    --             20
                                                         ------------    -------
  Net cash provided by (used in) financing activities....    350           (994)
                                                         ------------    -------
   Net increase (decrease) in cash.......................    (45)            43
                                                         ------------    -------
 Cash, beginning of period...............................     70            195
                                                         ------------    -------
 Cash, end of period..................................... $   25         $  238
                                                          ===========   ========
Supplemental Cash Flow Information:
   Cash paid for interest.................................$  339         $  471
   Cash paid for income taxes.............................$   --         $   --












          See accompanying notes to consolidated financial statements.



                                       4




               BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES



                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                 (In thousands)
                                   (unaudited)


Note 1 - Company and Basis of Presentation

     Blonder  Tongue   Laboratories,   Inc.  (the   "Company")  is  a  designer,
manufacturer  and supplier of  electronics  and systems  equipment for the cable
television  industry,  primarily  throughout the United States. The consolidated
financial statements include the accounts of Blonder Tongue  Laboratories,  Inc.
and  subsidiaries  (including  BDR  Broadband,  LLC).  Significant  intercompany
accounts and transactions have been eliminated in consolidation.

     The  Company's  investment  in Blonder  Tongue  Telephone,  LLC ("BTT") and
NetLinc  Communications,  LLC ("NetLinc") are accounted for on the equity method
since  the  Company  does not have  control  over  these  entities.  Information
relating to the Company's  rights and obligations with regard to BTT and NetLinc
are  summarized  in Note 1(a) to the  Company's  Form  10-K for the year ended
December 31, 2004.

     The  results  for the  second  quarter  and  six  months  of  2005  are not
necessarily  indicative  of the results to be expected  for the full fiscal year
and have not been  audited.  In the  opinion  of  management,  the  accompanying
unaudited consolidated financial statements contain all adjustments,  consisting
primarily of normal  recurring  accruals,  necessary for a fair statement of the
results of  operations  for the period  presented and the  consolidated  balance
sheet at June 30, 2005. Certain  information and footnote  disclosures  normally
included in financial  statements prepared in accordance with generally accepted
accounting  principles have been condensed or omitted  pursuant to the SEC rules
and regulations.  These financial  statements should be read in conjunction with
the financial  statements  and notes thereto that were included in the Company's
latest annual report on Form 10-K for the year ended December 31, 2004.

Note 2 - New Accounting Pronouncements

     In December, 2004, the Financial Accounting Standards Board ("FASB") issued
SFAS No. 123R,  "Share-Based  Payment." This statement is a revision to SFAS No.
123,  "Accounting for Stock-Based  Compensation"  and supersedes APB Opinion No.
25,  "Accounting  for Stock Issued to  Employees."  This  statement  establishes
standards for the accounting for  transactions in which an entity  exchanges its
equity  instruments for goods or services,  primarily focusing on the accounting
for  transactions  in which an entity obtains  employee  services in share-based
payment transactions. Companies will be required to measure the cost of employee
services  received in exchange for an award of equity  instruments  based on the
grant-date fair value of the award (with limited  exceptions).  The cost will be
recognized  over the period  during  which an  employee  is  required to provide
service in exchange for the award,  which requisite  service period will usually
be the vesting  period.  The grant-date fair value of employee share options and
similar instruments will be estimated using option-pricing  models. If an equity
award is modified after the grant date,  incremental  compensation  cost will be
recognized  in an amount  equal to the excess of the fair value of the  modified
award  over  the  fair  value  of the  original  award  immediately  before  the
modification.  SFAS No. 123R will be effective for fiscal years  beginning after
June  15,  2005  and  allows  for  several   alternative   transition   methods.
Accordingly, the Company will adopt SFAS No. 123R in its first quarter of fiscal
2006.  The Company is currently  evaluating  the provisions of SFAS No. 123R and
has not yet  determined  the impact that this Statement will have on its results
of operations or financial position.

     In November,  2004,  the FASB issued SFAS No. 151,  "Inventory  Costs",  an
amendment  of  Accounting  Research  Bulletin  No. 43  Chapter  4. SFAS No.  151
clarifies the accounting for abnormal amounts of idle facility expense, freight,
handling  costs and wasted  material.  SFAS No. 151 is effective  for  inventory
costs incurred  during fiscal years  beginning  after June 15, 2005. The Company
does not  believe  adoption  of SFAS No. 151 will have a material  effect on its
consolidated financial position, results of operations or cash flows.

     In December,  2004, the FASB issued FASB Staff Position No. 109-1 ("FSP FAS
No.  109-1"),  "Application  of FASB Statement No. 109,  'Accounting  for Income
Taxes,' to the Tax Deduction on Qualified Production  Activities Provided by the
American  Jobs  Creation  Act of 2004." The American  Jobs  Creation Act of 2004
introduces  a special  tax  deduction  of up to 9% when fully  phased in, of the
lesser of "qualified  production  activities  income" or taxable income. FSP FAS
109-1 clarifies that this tax deduction should be accounted for as a special tax



                                       5




               BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                 (In thousands)
                                   (unaudited)



deduction  in  accordance  with SFAS No.  109.  Although  FSP FAS No.  109-1 was
effective upon issuance,  the Company is still evaluating the impact FSP FAS No.
109-1 will have on its consolidated financial statements.

     In December,  2003, the FASB issued a revision to SFAS No. 132, "Employers'
Disclosures  about Pensions and Other  Postretirement  Benefits." This statement
does not change the  measurement or  recognition  aspects for pensions and other
post-retirement benefit plans; however, it does revise employers' disclosures to
include more information about the plan assets,  obligations to pay benefits and
funding  obligations.  SFAS No. 132,  as revised,  is  generally  effective  for
financial  statements  with a fiscal year ending after  December  15, 2003.  The
Company has adopted the  required  provisions  of SFAS No. 132, as revised.  The
adoption of the required provisions of SFAS No. 132, as revised,  did not have a
material effect on the Company's consolidated financial statements.

     In May,  2003,  the FASB  issued  SFAS No.  150,  "Accounting  for  Certain
Financial Instruments with Characteristics of both Liabilities and Equity." SFAS
No. 150  clarifies the  definition  of a liability as currently  defined in FASB
Concepts  Statement No. 6 "Elements of Financial  Statements,"  as well as other
planned revisions.  This statement requires a financial instrument that embodies
an obligation of an issuer to be  classified  as a liability.  In addition,  the
statement  establishes  standards for the initial and subsequent  measurement of
these  financial  instruments  and  disclosure  requirements.  SFAS  No.  150 is
effective for financial  instruments entered into or modified after May 31, 2003
and for all other  matters,  is effective at the  beginning of the first interim
period  beginning after June 15, 2003. The adoption of SFAS No. 150 did not have
a material effect on the Company's financial position or results of operations.

     In  January,   2003,  the  FASB  issued  Interpretation   ("FIN")  No.  46,
"Consolidation  of Variable  Interest  Entities" and in December 2003, a revised
interpretation  was issued  (FIN No. 46, as  revised).  In  general,  a variable
interest entity ("VIE") is a corporation partnership,  trust, or any other legal
structure used for business  purposes that either does not have equity investors
with  voting  rights or has  equity  investors  that do not  provide  sufficient
financial  resources  for the entity to support its  activities.  FIN No. 46, as
revised  requires  a VIE to be  consolidated  by a company  if that  company  is
designated  as the  primary  beneficiary.  The  interpretation  applies  to VIEs
created after January 31, 2003,  and for all financial  statements  issued after
December 15, 2003 for VIEs in which an enterprise held a variable  interest that
it acquired before February 1, 2003. The adoption of FIN No. 46, as revised, did
not have a material  effect on the  Company's  financial  position or results of
operations.

     In March,  2005, the Financial  Accounting  Standards Board ("FASB") issued
FASB interpretation ("FIN") No. 47, "Accounting for Conditional Asset Retirement
Obligations - An  Interpretation  of FASB  Statement No. 143" ("FIN 47"),  which
will result in (a) more consistent  recognition of liabilities relating to asset
retirement obligations, (b) more information about expected future cash outflows
associated with those obligations,  and (c) more information about investment in
long-lived  assets because  additional asset retirement costs will be recognized
as part of the carrying  amounts of the assets.  FIN 47 clarifies  that the term
conditional asset retirement obligation as used in SFAS No. 143, "Accounting for
Asset Retirement  Obligations," refers to a legal obligation to perform an asset
retirement  activity  in which  the  timing  and/or  method  of  settlement  are
conditional  on a future  event that may or may not be within the control of the
entity. The obligation to perform the asset retirement activity is unconditional
even though  uncertainty  exists about the timing and/or  method of  settlement.
Uncertainty  about the timing and/or method of settlement of a conditional asset
retirement  obligation  should be factored into the measurement of the liability
when sufficient  information  exists. FIN 47 also clarifies when an entity would
have  sufficient  information to reasonably  estimate the fair value of an asset
retirement obligation. FIN 47 is effective no later than the end of fiscal years
ending after  December 15, 2005. The Company plans to adopt FIN 47 at the end of
its 2005 fiscal year and does not believe that the adoption will have a material
impact on its results of operations or financial position.

Note 3 - Stock Options

     The Company  applies APB Opinion  No. 25,  Accounting  for Stock  Issued to
Employees, and related interpretations in accounting for its stock option plans.
Statement of Financial Accounting Standards No. 123 ("FAS 123"),  Accounting for
Stock-Based Compensation,  requires the Company to provide pro forma information
regarding  net  income  (loss) and net  income  (loss)  per  common  share as if
compensation cost for stock options granted under the plans, if applicable,  had
been determined in accordance with the fair value based method prescribed in FAS
123. The Company  does not plan to adopt the fair value based method  prescribed
by FAS 123.



                                       6




               BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                 (In thousands)
                                   (unaudited)


     The Company  estimates  the fair value of each stock  option grant by using
the  Black-Scholes  option-pricing  model with the  following  weighted  average
assumptions  used for grants made during the three  months ended March 31, 2005:
expected  lives of 9.5 years,  no dividend  yield,  volatility at 73%, risk free
interest  rate of 3.2% for 2005.  No options were granted  during the six months
ended June 30, 2004 and the three months ended June 30, 2005.

     Under  accounting  provisions  of FAS 123, the Company's net loss to common
shareholders  and net loss per common share would have been  adjusted to the pro
forma amounts indicated below (in thousands, except per share data):



                          Three Months Ended June 30,  Six Months Ended June 30,
                          ---------------------------  -------------------------
                              2005          2004           2005           2004
                          ------------   -----------    ----------   -----------
  Net earnings (loss) as
    reported ..............  $ (641)        $236         $(1,531)         $ (161)
Adjustment for fair value
    of stock options....        160           47             319              94
                            ----------     ---------    -----------    ---------
     Pro forma.........      $ (801)        $189         $(1,850)         $ (255)
                            ===========    =========    ===========    =========
 Net (earnings) loss per
  share basic anddiluted:
     As reported............ $(0.08)       $0.03         $ (0.19)         $(0.02)
                            ===========    =========    ===========   ==========
     Pro forma............   $(0.10)       $0.02         $ (0.23)         $(0.03)
                            ===========    =========    ===========   ==========




Note 4 - Inventories

         Inventories net of reserves are summarized as follows:

                                                  June 30,         Dec. 31,
                                                    2005             2004
                                              ---------------   -------------
 Raw Materials................................    $10,499           $11,308
 Work in process..............................      1,816             1,698
 Finished Goods...............................     10,212            10,615
                                               ---------------   -------------
                                                   22,527            23,621
 Less current inventory.......................     (9,169)          (10,309)
                                               ---------------   -------------
                                                   13,358            13,312
 Less Reserve primarily for excess inventory..     (5,223)           (4,344)
                                               ---------------   -------------
                                                   $8,135            $8,968
                                               ===============   =============


     Inventories  are stated at the lower of cost,  determined  by the first-in,
first-out ("FIFO") method, or market.

     The  Company  periodically  analyzes  anticipated  product  sales  based on
historical  results,  current  backlog  and  marketing  plans.  Based  on  these
analyses,  the Company anticipates that certain products will not be sold during
the next twelve months.  Inventories  that are not anticipated to be sold in the
next twelve months, have been classified as non-current.

     Over 60% of the non-current inventories are comprised of raw materials. The
Company has  established a program to use  interchangeable  parts in its various
product  offerings and to modify  certain of its finished  goods to better match
customer demands. In addition,  the Company has instituted  additional marketing
programs to dispose of the slower moving inventories.

     The Company  continually  analyzes  its  slow-moving,  excess and  obsolete
inventories.  Based on historical  and projected  sales volumes and  anticipated
selling prices, the Company establishes  reserves.  If the Company does not meet
its  sales  expectations,  these  reserves  are  increased.  Products  that  are
determined to be obsolete are written down to net realizable  value. The Company


                                       7



               BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                 (In thousands)
                                   (unaudited)

believes  reserves are adequate and  inventories are reflected at net realizable
value.

Note 5 - Debt

     On March 20, 2002 the Company entered into a credit agreement with Commerce
Bank, N.A. for a $19,500 credit  facility,  comprised of (i) a $7,000  revolving
line of credit under which funds may be borrowed at LIBOR, plus a margin ranging
from  1.75% to 2.50%,  in each case  depending  on the  calculation  of  certain
financial  covenants,  with a floor of 5% through March 19, 2003,  (ii) a $9,000
term loan which bore interest at a rate of 6.75% through September 30, 2002, and
thereafter  at a fixed  rate  ranging  from  6.50% to  7.25% to reset  quarterly
depending on the calculation of certain  financial  covenants and (iii) a $3,500
mortgage loan bearing  interest at 7.5%.  Borrowings under the revolving line of
credit are limited to certain  percentages of eligible  accounts  receivable and
inventory,  as  defined  in  the  credit  agreement.   The  credit  facility  is
collateralized  by a  security  interest  in all of the  Company's  assets.  The
agreement  also  contains  restrictions  that  require  the  Company to maintain
certain  financial  ratios  as  well  as  restrictions  on the  payment  of cash
dividends.  The initial  maturity  date of the line of credit with Commerce Bank
was March 20, 2004. The term loan required equal monthly  principal  payments of
$187 and matures on April 1, 2006.  The mortgage  loan  requires  equal  monthly
principal  payments of $19 and matures on April 1, 2017.  The  mortgage  loan is
callable after five years at the lender's option.

     In November,  2003, the Company's  credit  agreement with Commerce Bank was
amended to modify the interest rate and amortization schedule for certain of the
loans thereunder, as well as to modify one of the financial covenants. Beginning
November 1, 2003,  the revolving  line of credit bore interest at the prime rate
plus 1.5%, with a floor of 5.5%, and the term loan began to accrue interest at a
fixed rate of 7.5%.  Beginning  December 1, 2003,  the term loan requires  equal
monthly  principal  payments of $193 plus interest with a final payment on April
1, 2006 of all remaining unpaid principal and interest.

     At March 31, 2003, June 30, 2003, September 30, 2003 and December 31, 2003,
the Company was unable to meet one of its financial covenants required under its
credit agreement with Commerce Bank, which non-compliance was waived by the Bank
effective as of each such date.

     In March,  2004,  the  Company's  credit  agreement  with Commerce Bank was
amended to (i) extend the  maturity  date of the line of credit  until  April 1,
2005,  (ii)  reduce the maximum  amount  that may be borrowed  under the line of
credit to $6,000,  (iii)  suspend the  applicability  of the cash flow  coverage
ratio  covenant  until  March 31,  2005,  (iv) impose a new  financial  covenant
requiring the Company to achieve certain levels of  consolidated  pre-tax income
on a quarterly  basis  commencing  with the fiscal quarter ended March 31, 2004,
and (v) require that the Company make a prepayment  against its outstanding term
loan to the Bank equal to 100% of the amount of any  prepayment  received by the
Company on its  outstanding  note  receivable  from a customer,  up to a maximum
amount of $500.

     At December 31, 2004,  the Company was unable to meet one of its  financial
covenants  required  under  its  credit  agreement  with  Commerce  Bank,  which
non-compliance was waived by the Bank effective as of such date.

     In March,  2005,  the  Company's  credit  agreement  with Commerce Bank was
amended to (i) extend the  maturity  date of the line of credit  until  April 1,
2006,  (ii) provide for a interest rate on the  revolving  line of credit of the
prime rate plus 2.0%, with a floor of 5.5% (8.0% at June 30, 2005),  (iii) waive
the applicability of consolidated  pre-tax income for the quarter ended December
31,  2004,  (iv)  suspend  the  applicability  of the cash flow  coverage  ratio
covenant until March 31, 2006, and (v) impose a financial covenant requiring the
Company to achieve certain levels of consolidated  pre-tax income on a quarterly
basis commencing with the fiscal quarter ended March 31, 2005.

     At March 31,  2005 and June 30,  2005,  the  Company was unable to meet its
quarterly  consolidated  pre-tax  income  covenant  required  under  its  credit
agreement  with  Commerce  Bank,  which  non-compliance  was  waived by the Bank
effective as of such dates. The Company has continued to treat amounts due under
the credit  agreement  beyond one year as non-current as it believed at the time
of each such  analysis  that it was  probable  that the  Company  would meet the
future quarterly  consolidated  pre-tax income covenant for the remainder of the
agreement comprising of the remaining 2005 fiscal quarters. The Company's belief
that it was probable that it would be in compliance with such covenant was based
upon  its  projected  consolidated  pre-tax  income  for  such  quarters,  which
projection includes an analysis of, among other things, order input, outstanding
sales quotations and backlog.



                                       8



               BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                 (In thousands)
                                   (unaudited)


Note 6 - Cable Systems and Telephone Products (Subscribers and passings in whole
         numbers)

     During June, 2002, the Company formed a venture with Priority Systems,  LLC
and  Paradigm  Capital  Investments,  LLC  for  the  purpose  of  acquiring  the
rights-of-entry  for certain  multiple  dwelling unit ("MDU")  cable  television
systems (the "Systems") owned by affiliates of Verizon Communications,  Inc. The
venture entity,  BDR Broadband,  LLC ("BDR  Broadband"),  90% of the outstanding
capital stock of which is owned by the Company,  acquired the Systems, which are
comprised of approximately  2,920 existing MDU cable television  subscribers and
approximately  6,969 passings.  BDR Broadband paid approximately  $1,880 for the
Systems, subject to adjustment,  which constitutes a purchase price of $.575 per
subscriber.  The final closing date for the  transaction was on October 1, 2002.
The Systems were cash flow positive  beginning in the first year.  To date,  the
Systems have been upgraded with  approximately  $1,348 of interdiction and other
products of the Company and, during 2004, two of the Systems located outside the
region where the  remaining  Systems are located,  were sold. It is planned that
the Systems will be upgraded with approximately $400 of additional  interdiction
and other  products of the Company  over the course of  operation.  During July,
2003,  the Company  purchased  the 10% interest in BDR  Broadband  that had been
originally owned by Paradigm Capital Investments, LLC, for an aggregate purchase
price of $35,  resulting in an increase in the Company's  stake in BDR Broadband
from 80% to 90%.

     The purchase  price was  allocated  $1,524 to  rights-of-entry  and $391 to
fixed assets. The rights-of-entry are being amortized over a five-year period.

     In consideration  for its majority  interest in BDR Broadband,  the Company
advanced to BDR Broadband $250,  which was paid to the sellers as a down payment
against the final  purchase  price for the  Systems.  The Company also agreed to
guaranty  payment  of the  aggregate  purchase  price  for  the  Systems  by BDR
Broadband.  The  approximately  $1,630 balance of the purchase price was paid by
the  Company on behalf of BDR  Broadband  on November  30, 2002  pursuant to the
terms and in satisfaction of certain  promissory notes executed by BDR Broadband
in favor of the sellers.

     In March,  2003, the Company entered into a series of agreements,  pursuant
to which the Company acquired a 20% minority interest in NetLinc Communications,
LLC ("NetLinc")  and a 35% minority  interest in Blonder Tongue  Telephone,  LLC
("BTT") (to which the Company has licensed  its name).  The  aggregate  purchase
price  consisted of (i) up to $3,500  payable over a minimum of two years,  plus
(ii) 500 shares of the Company's common stock. NetLinc owns patents, proprietary
technology and know-how for certain  telephony  products that allow  Competitive
Local  Exchange  Carriers  ("CLECs") to  competitively  provide voice service to
MDUs.  Certain  distributorship  agreements were also concurrently  entered into
among  NetLinc,  BTT and the Company  pursuant  to which the Company  ultimately
acquired the right to  distribute  NetLinc's  telephony  products to private and
franchise cable operators as well as to all buyers for use in MDU  applications.
BTT partners  with CLECs to offer  primary  voice  service to MDUs,  receiving a
portion of the line  charges due from the CLECs'  telephone  customers,  and the
Company  offers for sale a line of telephony  equipment to complement  the voice
service.

     As a result of  NetLinc's  inability to retain a contract  manufacturer  to
manufacture  and  supply  the  products  in a timely  and  consistent  manner in
accordance  with the requisite  specifications,  in September,  2003 the parties
agreed to restructure  the terms of their business  arrangement  entered into in
March, 2003. The restructured  business arrangement was accomplished by amending
certain of the agreements  previously entered into and entering into certain new
agreements.  Some of the principal terms of the restructured arrangement include
increasing  the Company's  economic  ownership in NetLinc from 20% to 50% and in
BTT from 35% to 50%, all at no additional cost to the Company.  The cash portion
of the purchase price in the venture was decreased from $3,500 to $1,167 and the
then outstanding  balance of $342 was paid in installments of $50 per week until
it was paid in full in October, 2003. BTT has an obligation to redeem the $1,167
cash  component  of  the  purchase   price  to  the  Company  via   preferential
distributions  of cash flow under  BTT's  limited  liability  company  operating
agreement.  In addition,  of the 500 shares of common stock issued to BTT as the
non-cash component of the purchase price (fair valued at $1,030),  one-half (250
shares) have been pledged to the Company as collateral.  Under the  restructured
arrangement,  the Company can purchase similar telephony  products directly from
third party  suppliers  other than NetLinc  and, in  connection  therewith,  the
Company would pay certain  future  royalties to NetLinc and BTT from the sale of


                                       9



               BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                 (In thousands)
                                   (unaudited)

these  products  by the  Company.  While the  distributorship  agreements  among
NetLinc,  BTT and the Company  have not been  terminated,  the Company  does not
anticipate purchasing products from NetLinc in the near term. NetLinc,  however,
continues to own intellectual property,  which may be further developed and used
in  the  future  to   manufacture   and  sell   telephony   products  under  the
distributorship  agreements. The Company accounts for its investments in NetLinc
and BTT using the equity method.

Note 7 - Notes Receivable

     During   September,   2002,  the  Company  sold  inventory  at  a  cost  of
approximately  $1,447 to a private cable  operator for  approximately  $1,929 in
exchange for which the Company received notes receivable in the principal amount
of  approximately  $1,929.  The notes were payable by the customer in 48 monthly
principal and interest (at 11.5%)  installments of approximately  $51 commencing
January  1,  2003.  The  customer's  payment  obligations  under the notes  were
collateralized  by purchase money liens on the inventory sold and blanket second
liens on all other  assets  of the  customer.  The  Company  recorded  the notes
receivable  at the  inventory  cost and did not  recognize  any revenue or gross
profit  on the  transaction  until a  substantial  amount  of the  cost had been
recovered,  and  collectibility  was  assured.  The  balances  of the notes were
collected during the last three quarters of 2004 and approximately $482 of gross
margin and $356 of interest income was recognized.

Note 8 - Related Party Transactions

     On  January  1,  1995,   the  Company   entered  into  a   consulting   and
non-competition  agreement with a director, who is also the largest stockholder.
Under the  agreement,  the  director  provides  consulting  services  on various
operational and financial  issues and as of June 30, 2005, was paid at an annual
rate of $152 but in no event is such annual rate  permitted to exceed $200.  The
director also agreed to keep all Company  information  confidential and will not
compete  directly or  indirectly  with the Company for the term of the agreement
and for a period of two years  thereafter.  The initial  term of this  agreement
expired on December 31, 2004 and automatically  renews thereafter for successive
one-year  terms  (subject to  termination  at the end of the initial term or any
renewal term on at least 90 days' notice). This agreement  automatically renewed
for a one-year extension until December 31, 2005.

     As of June 30,  2005,  the Chief  Executive  Officer  was  indebted  to the
Company in the amount of $190,  for which no  interest  has been  charged.  This
indebtedness  arose  from a series  of cash  advances,  the  latest of which was
advanced in February  2002 and is included in other  assets at June 30, 2005 and
December 31, 2004.

     The President of the Company lent the Company 100% of the purchase price of
certain  used-equipment  inventory  purchased by the Company in October  through
November of 2003.  The  inventory  was  purchased at a  substantial  discount to
market  price.  While the  aggregate  cost to purchase all of the  inventory was
approximately  $950,  the  maximum  amount of  indebtedness  outstanding  to the
President at any one time during 2004 was $675.  The Company repaid this loan in
full in July, 2004. The President made the loan to the Company on a non-recourse
basis,  secured solely by a security interest in the inventory  purchased by the
Company  and  the  proceeds  resulting  from  the  sale  of  the  inventory.  In
consideration for the extension of credit on a non-recourse basis, the President
received  from the  Company  interest on the  outstanding  balance at the margin
interest  rate he incurred for  borrowing the funds from his lenders plus 25% of
the gross profit  derived from the Company's  resale of such  inventory.  During
2004,  interest  on the loan paid to the  President  was $12. In  addition,  the
President was paid $33,  representing  an advance  payment  against his share of
gross  profit  derived  from the resale of such  equipment,  the final amount of
which will be determined as of December 31, 2005. In April,  2004, the President
of the Company acquired $75 of used equipment inventory,  which was subsequently
sold by him to the Company on a  consignment  basis.  Payment by the Company for
the goods becomes due upon the sale thereof by the Company and collection of the
accounts receivable generated by such sales. In connection with the transaction,
the  Company  agreed to pay the  President  cost  plus 25% of the  gross  profit
derived  from  the  sale of such  inventory.  At June 30,  2005,  the  aggregate
remaining  outstanding  balance  due to  the  President  from  the  sale  of the
consigned goods was approximately $4 and was included in other accrued expenses.

     In March,  2003, the Company entered into a series of agreements,  pursuant
to which the Company acquired a 20% minority interest in NetLinc Communications,
LLC ("NetLinc")  and a 35% minority  interest in Blonder Tongue  Telephone,  LLC
("BTT").  During  September,  2003, the parties  restructured the terms of their
business  arrangement,  which  included  increasing  Blonder  Tongue's  economic
ownership  in  NetLinc  from 20% to 50% and in BTT  from  35% to 50%,  all at no


                                       10



               BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                 (In thousands)
                                   (unaudited)


additional cost to Blonder Tongue. The cash portion of the purchase price in the
venture was decreased from $3,500 to $1,167, and was paid in full by the Company
to BTT in October,  2003. As the non-cash  component of the purchase price,  the
Company issued 500 shares of its common stock to BTT,  resulting in BTT becoming
the owner of greater than 5% of the outstanding common stock of the Company. The
Company  will  receive  preferential  distributions  equal  to the  $1,167  cash
component  of the  purchase  price from the cash flows of BTT.  One-half of such
common  stock (250  shares)  has been  pledged to the Company as  collateral  to
secure BTT's obligation.  Under the restructured  arrangement,  the Company pays
certain future royalties to NetLinc and BTT upon the sale of telephony products.
Through this telephony venture, BTT offers primary voice service to MDUs and the
Company  offers for sale a line of telephony  equipment to complement  the voice
service.


                                    11






ITEM 2.       MANAGEMENT'S  DISCUSSION  AND ANALYSIS OF FINANCIAL  CONDITION AND
              RESULTS OF OPERATIONS

Forward-Looking Statements

     In addition to  historical  information,  this  Quarterly  Report  contains
forward-looking  statements  relating to such matters as  anticipated  financial
performance,  business  prospects,  technological  developments,  new  products,
research and development  activities and similar matters. The Private Securities
Litigation  Reform  Act of  1995  provides  a safe  harbor  for  forward-looking
statements.  In order to comply with the terms of the safe  harbor,  the Company
notes that a variety of factors  could cause the  Company's  actual  results and
experience  to  differ   materially  from  the  anticipated   results  or  other
expectations expressed in the Company's  forward-looking  statements.  The risks
and uncertainties  that may affect the operation,  performance,  development and
results of the Company's business include, but are not limited to, those matters
discussed  herein in the section  entitled Item 2 - Management's  Discussion and
Analysis of Financial Condition and Results of Operations.  The words "believe",
"expect",    "anticipate",    "project"   and   similar   expressions   identify
forward-looking statements. Readers are cautioned not to place undue reliance on
these forward-looking statements, which reflect management's analysis only as of
the date hereof.  The Company  undertakes no obligation to publicly revise these
forward-looking  statements to reflect events or circumstances  that arise after
the date hereof.  Readers should carefully review the risk factors  described in
other  documents  the Company  files from time to time with the  Securities  and
Exchange Commission,  including without limitation,  the Company's Annual Report
on Form 10-K for the year ended December 31, 2004 (See Item 1 - Business; Item
3 -  Legal  Proceedings;  Item  7 -  Management's  Discussion  and  Analysis  of
Financial Condition and Results of Operations; and Risk Factors).

General

     The Company was incorporated in November,  1988, under the laws of Delaware
as  GPS  Acquisition  Corp.  for  the  purpose  of  acquiring  the  business  of
Blonder-Tongue Laboratories, Inc., a New Jersey corporation which was founded in
1950 by Ben H. Tongue and Isaac S. Blonder to design,  manufacture  and supply a
line of  electronics  and systems  equipment  principally  for the Private Cable
industry.  Following the  acquisition,  the Company  changed its name to Blonder
Tongue  Laboratories,  Inc. The Company completed the initial public offering of
its shares of common stock in December, 1995.

     The Company is  principally  a  designer,  manufacturer  and  supplier of a
comprehensive line of electronics and systems equipment, primarily for the cable
television industry (both franchise and private cable). Over the past few years,
the Company has also  introduced  equipment  and  innovative  solutions  for the
high-speed  transmission  of data and the  provision  of  telephony  services in
multiple dwelling unit applications. The Company's products are used to acquire,
distribute  and  protect the broad range of  communications  signals  carried on
fiber optic,  twisted  pair,  coaxial cable and wireless  distribution  systems.
These  products  are sold to  customers  providing  an  array of  communications
services,  including  television,  high-speed data (Internet) and telephony,  to
single family  dwellings,  multiple  dwelling  units,  the lodging  industry and
institutions  such as  hospitals,  prisons,  schools and marinas.  The Company's
principal  customers are cable system  integrators  (both  franchise and private
cable operators,  as well as contractors) that design,  package,  install and in
most instances operate, upgrade and maintain the systems they build.

     The Company's  success is due in part to  management's  efforts to leverage
the Company's  reputation by broadening  its product line to offer one-stop shop
convenience  to private  cable and  franchise  cable system  integrators  and to
deliver products having a high performance-to-cost  ratio. The Company continues
to expand its core product  lines  (headend and  distribution),  to maintain its
ability to provide all of the electronic  equipment  needed to build small cable
systems  and  much of the  equipment  needed  in  larger  systems  for the  most
efficient operation and highest profitability in high density applications.

     In March,  1998,  the  Company  acquired  all of the assets and  technology
rights,  including  the  SMI  Interdiction  product  line,  of the  interdiction
business  of   Scientific-Atlanta,   Inc.  The  Company  is  utilizing  the  SMI
Interdiction  product  line  acquired  from  Scientific-Atlanta,  which has been
engineered primarily to serve the franchise cable market, as a supplement to the
Company's VideoMask(TM)Interdiction products, which are primarily focused on the
private cable market.


                                       12



     Over the past  several  years,  the  Company has  expanded  beyond its core
business by acquiring a private cable  television  system (BDR Broadband,  LLC )
and by acquiring an interest in a company offering a private  telephone  program
ideally suited to multiple dwelling unit applications (Blonder Tongue Telephone,
LLC). These acquisitions are described in more detail below.

     During June, 2002, the Company formed a venture with Priority Systems,  LLC
and  Paradigm  Capital  Investments,  LLC  for  the  purpose  of  acquiring  the
rights-of-entry for certain multiple dwelling unit cable television systems (the
"Systems")  owned by  affiliates  of Verizon  Communications,  Inc.  The venture
entity, BDR Broadband, 90% of the outstanding capital stock of which is owned by
the Company,  acquired the Systems,  which are comprised of approximately  2,920
existing MDU cable television  subscribers and approximately 6,969 passings. BDR
Broadband paid approximately  $1,880,000 for the Systems, subject to adjustment,
which  constitutes a purchase  price of $575 per  subscriber.  The final closing
date for the  transaction  was on October 1, 2002.  The  Systems  were cash flow
positive  beginning in the first year.  To date,  the Systems have been upgraded
with approximately  $1,348,000 of interdiction and other products of the Company
and,  during  2004,  two of the Systems  located  outside  the region  where the
remaining Systems are located, were sold. It is planned that the Systems will be
upgraded  with  approximately  $400,000  of  additional  interdiction  and other
products of the Company over the course of  operation.  During July,  2003,  the
Company  purchased  the 10% interest in BDR Broadband  that had been  originally
owned by Paradigm Capital  Investments,  LLC, for an aggregate purchase price of
$35,000,  resulting in an increase in the Company's  stake in BDR Broadband from
80% to 90%.

     In consideration  for its majority  interest in BDR Broadband,  the Company
advanced  to BDR  Broadband  $250,000,  which was paid to the  sellers as a down
payment  against the final  purchase  price for the  Systems.  The Company  also
agreed to guaranty  payment of the aggregate  purchase  price for the Systems by
BDR Broadband.  The approximately  $1,630,000  balance of the purchase price was
paid by the Company on behalf of BDR Broadband on November 30, 2002, pursuant to
the terms and in satisfaction of certain  promissory  notes (the "Seller Notes")
executed by BDR Broadband in favor of the sellers.

     The Company  believes that the model it devised for acquiring and operating
the Systems has been  successful and can be replicated  for other  transactions.
The  Company  also  believes  that  opportunities  currently  exist  to  acquire
additional   rights-of-entry   for  multiple  dwelling  unit  cable  television,
high-speed data and/or telephony systems. The Company is seeking  opportunities,
although  there  is  no  assurance  that  the  Company  will  be  successful  in
consummating any  transactions.  In addition,  the Company may need financing to
acquire the  additional  rights-of-entry,  and financing may not be available on
acceptable terms or at all.

     In March,  2003, the Company entered into a series of agreements,  pursuant
to which the Company acquired a 20% minority interest in NetLinc Communications,
LLC ("NetLinc")  and a 35% minority  interest in Blonder Tongue  Telephone,  LLC
("BTT") (to which the Company has licensed  its name).  The  aggregate  purchase
price  consisted  of (i) up to  $3,500,000  payable over a minimum of two years,
plus (ii) 500,000  shares of the Company's  common stock.  NetLinc owns patents,
proprietary  technology and know-how for certain  telephony  products that allow
Competitive  Local Exchange  Carriers  ("CLECs") to competitively  provide voice
service  to MDUs.  Certain  distributorship  agreements  were also  concurrently
entered into among  NetLinc,  BTT and the Company  pursuant to which the Company
ultimately  acquired the right to  distribute  NetLinc's  telephony  products to
private and  franchise  cable  operators as well as to all buyers for use in MDU
applications.  BTT partners  with CLECs to offer  primary voice service to MDUs,
receiving a portion of the line charges due from the CLECs' telephone customers,
and the Company offers for sale a line of telephony  equipment to complement the
voice service.

     As a result of  NetLinc's  inability to retain a contract  manufacturer  to
manufacture  and  supply  the  products  in a timely  and  consistent  manner in
accordance  with the requisite  specifications,  in September,  2003 the parties
agreed to restructure  the terms of their business  arrangement  entered into in
March, 2003. The restructured  business arrangement was accomplished by amending
certain of the agreements  previously entered into and entering into certain new
agreements.  Some of the principal terms of the restructured arrangement include
increasing  the Company's  economic  ownership in NetLinc from 20% to 50% and in
BTT from 35% to 50%, all at no additional cost to the Company.  The cash portion
of the purchase price in the venture was decreased from $3,500,000 to $1,166,667
and the then outstanding balance of $342,000 was paid in installments of $50,000
per week until it was paid in full in October, 2003. In addition, of the 500,000


                                       13



shares of common stock  issued to BTT as the non-cash  component of the purchase
price (fair valued at $1,030,000),  one-half  (250,000 shares) have been pledged
to the Company as collateral to secure BTT's  obligation to repay the $1,167,667
cash  component  of  the  purchase   price  to  the  Company  via   preferential
distributions  of cash flow under  BTT's  limited  liability  company  operating
agreement. Under the restructured arrangement,  the Company can purchase similar
telephony  products  directly from third party suppliers other than NetLinc and,
in  connection  therewith,  the Company  would pay certain  future  royalties to
NetLinc  and BTT from  the sale of these  products  by the  Company.  While  the
distributorship  agreements  among  NetLinc,  BTT and the Company  have not been
terminated,  the Company does not anticipate purchasing products from NetLinc in
the near term. NetLinc,  however,  continues to own intellectual property, which
may be  further  developed  and  used in the  future  to  manufacture  and  sell
telephony products under the distributorship agreements.

     In addition to receiving  incremental  revenues  associated with its direct
sales  of  the  telephony  products,  the  Company  also  anticipates  receiving
additional revenues from telephony services provided by or through contracts for
such services  obtained by BDR  Broadband,  BTT (through the Company's 50% stake
therein) as well as through joint ventures with third parties.  While the events
related to the  restructuring  resulted in a delay in the Company's  anticipated
revenue stream from the sale of telephony  products,  the Company  believes that
these  revised  terms are  beneficial  and will result in the  Company  enjoying
higher  gross  margins  on  telephony   equipment  unit  sales  as  well  as  an
incrementally  higher proportion of telephony service revenues.  It has been the
Company's  experience during the past year that the time frame from introduction
of  a  telephony   service   opportunity  to   consummation  of  the  associated
right-of-entry  agreement,  is longer than the time frame  relating to obtaining
rights-of-entry  for the provision of video and high-speed  data services.  This
protracted  time  frame has had an  adverse  impact on the  growth of  telephony
system  revenues.  Material  incremental  revenues  associated  with the sale of
telephony  products are not presently  anticipated to be received until at least
fiscal year 2006.

Results of Operations

Second three months of 2005 Compared with second three months of 2004.

     Net Sales. Net sales decreased  $1,509,000,  or 13.8%, to $9,408,000 in the
second three months of 2005 from $10,917,000 in the second three months of 2004.
The decrease in sales is primarily attributed to lower head end sales. Net sales
included  approximately  $4,835,000 and $5,522,000 of headend  equipment for the
second  three months of 2005 and 2004,  respectively.  Included in net sales are
revenues from BDR Broadband of $452,000 and $393,000 for the second three months
of 2005 and 2004, respectively.

     Cost of Goods Sold.  Cost of goods sold  decreased  to  $6,549,000  for the
second three months of 2005 from  $7,837,000 for the second three months of 2004
and  decreased as a percentage  of sales to 69.6% from 71.8%.  The decrease as a
percentage  of sales was caused  primarily  by a higher  portion of sales in the
period being comprised of higher margin products.

     Selling Expenses.  Selling expenses  increased to $1,124,000 for the second
three  months of 2005 from  $1,093,000  in the second  three  months of 2004 and
increased as a percentage  of sales to 12.0% for the second three months of 2005
from  10.0% for the  second  three  months of 2004.  The  $31,000  increase  was
primarily  due to an increase in salaries and fringe  benefits of $84,000 due to
an increase in headcount, offset by a decrease of $59,000 in royalty expenses.

     General and Administrative  Expenses.  General and administrative  expenses
increased to $1,681,000 for the second three months of 2005 from  $1,349,000 for
the second three months of 2004 and  increased as a percentage of sales to 17.9%
for the second  three  months of 2005 from 12.4% for the second  three months of
2004.  The  $332,000  increase  was  primarily  attributed  to  an  increase  in
professional fees of $214,000 relating to BTT.

     Research  and  Development  Expenses.  Research  and  development  expenses
increased to $395,000 in the second  three  months of 2005 from  $391,000 in the
second  three  months  of 2004,  primarily  due to an  increase  in  maintenance
expenses of $5,000. Research and development expenses, as a percentage of sales,
increased  to 4.2% in the  second  three  months of 2005 from 3.6% in the second
three months of 2004.


                                       14



     Operating  Income  (Loss).  Operating loss of $341,000 for the second three
months of 2005  represents a decrease from operating  income of $247,000 for the
second three months of 2004. Operating income as a percentage of sales decreased
to (3.6)% in the  second  three  months  of 2005 from 2.3% in the  second  three
months of 2004.

     Other Expense.  Interest expense  decreased to $203,000 in the second three
months of 2005 from $223,000 in the second three months of 2004. The decrease is
the result of lower average borrowing.  Interest income decreased to zero in the
second three  months of 2005  compared to $212,000 in the second three months of
2004 primarily due to the  recognition of $136,000 of interest  income on a note
receivable (see footnote 7 in the notes to the Company's unaudited  consolidated
financial statements contained in this Form 10-Q).

     Income Taxes. The provision for income taxes for the second three months of
2005 and 2004 was zero. As a result of the Company's  continuing  losses, a 100%
valuation  allowance  has been  recorded  on the 2005 and 2004  increase  in the
deferred tax benefit.

First six months of 2005 Compared with first six months of 2004

     Net Sales.  Net sales  decreased  $769,000,  or 4.0%, to $18,677,000 in the
first six months of 2005 from  $19,446,000  in the first six months of 2004. The
decrease in sales is  primarily  attributed  to the  recognition  of $745,000 of
sales from the note receivable in the first six months of 2004.  Included in net
sales are revenues from BDR Broadband of $869,000 and $739,000 for the first six
months of 2005 and 2004, respectively.

     Cost of Goods Sold.  Cost of goods sold  decreased to  $13,291,000  for the
first six months of 2005 from  $13,425,000 for the first six months of 2004, and
decreased  as a  percentage  of sales to 71.2% from  69.0%.  The  decrease  as a
percentage  of sales was caused  primarily  by an  increase  in the  reserve for
excess  inventory  of  $879,000  in the first six  months  of 2005  compared  to
$300,000 for the first six months of 2004. The increase in the inventory reserve
is due to increased reserves for raw material components.

     Selling Expenses. Selling expenses increased to $2,190,000 in the first six
months of 2005 from $2,138,000 in the first six months of 2004, and increased as
a  percentage  of sales to 11.7% for the first six months of 2005 from 11.0% for
the first six months of 2004. This $52,000 increase is primarily attributable to
an  increase  in wages and fringe  benefits  of  $189,000  due to an increase in
headcount  offset by a decrease of $123,000 in royalty expense for the first six
months of 2005.

     General and Administrative  Expenses.  General and administrative  expenses
increased to $3,334,000 for the first six months of 2005 from $2,956,000 for the
first six months of 2004 and increased as a percentage of sales to 17.9% for the
first  six  months of 2005 from  15.2%  for the  first six  months of 2004.  The
$378,000  increase can be primarily  attributed  to an increase in  professional
fees of $214,000 relating to BTT.

     Research  and  Development  Expenses.  Research  and  development  expenses
increased to $806,000 in the first six months of 2005 from $802,000 in the first
six months of 2004.  This  increase was  primarily  due to a $5,000  increase in
maintenance  expense.  Research and  development  expenses,  as a percentage  of
sales,  increased to 4.3% in the first six months of 2005 from 4.1% in the first
six months of 2003.

     Operating  (Loss)  Income.  Operating  loss was  $944,000 for the first six
months of 2005 compared to income of $125,000 for the first six months of 2004.

     Other  Expense.  Interest  expense  decreased  to $396,000 in the first six
months of 2005 from  $498,000 in the first six months of 2004.  The  decrease is
the result of lower average borrowing.  Interest income decreased to zero in the
first six months of 2005  compared to $212,000  for the first six months of 2004
primarily  due to the  recognition  of $136,000  of interest  income on the note
receivable described above.

     Income Taxes. The benefit for income taxes for the first six months of 2005
and 2004 was zero.  The benefit for the current  year loss has been subject to a
valuation  allowance  since the  realization  of the deferred tax benefit is not
considered more likely than not.


                                       15



Liquidity and Capital Resources

     As of June 30, 2005 and December 31, 2004,  the Company's  working  capital
was $7,211,000 and $10,603,000, respectively. The decrease in working capital is
attributable  primarily  to an  increase  in the  current  portion  of  debt  of
$4,461,000  due to the  reclassification  of the  revolving  line of  credit  to
current at June 30, 2005.

     The  Company's  net cash used in  operating  activities  for the  six-month
period  ended  June 30,  2005 was  $44,000,  compared  to net cash  provided  by
operating  activities  for the six-month  period ended June 30, 2004,  which was
$338,000.  The  decrease is  attributable  primarily  to an increase in accounts
receivable of $2,320,000 offset by a decrease in inventories of $1,094,000.

     Cash  used in  investing  activities  was  $351,000,  which  was  primarily
attributable to capital  expenditures  for new equipment and upgrades to the BDR
Broadband Systems of $348,000.

     Cash provided by financing activities was $350,000 for the first six months
of 2005 primarily  comprised of $7,170,000 of borrowings offset by $6,820,000 of
repayments of debt.

     On March 20, 2002 the Company entered into a credit agreement with Commerce
Bank,  N.A. for a  $19,500,000  credit  facility,  comprised of (i) a $7,000,000
revolving  line of credit  under which  funds may be  borrowed at LIBOR,  plus a
margin ranging from 1.75% to 2.50%, in each case depending on the calculation of
certain financial  covenants,  with a floor of 5% through March 19, 2003, (ii) a
$9,000,000  term loan which bore interest at a rate of 6.75%  through  September
30, 2002,  and  thereafter  at a fixed rate ranging from 6.50% to 7.25% to reset
quarterly depending on the calculation of certain financial covenants, and (iii)
a  $3,500,000  mortgage  loan  bearing  interest at 7.5%.  Borrowings  under the
revolving line of credit are limited to certain percentages of eligible accounts
receivable  and  inventory,  as  defined  in the  credit  agreement.  The credit
facility  is  collateralized  by a  security  interest  in all of the  Company's
assets.  The agreement  also contains  restrictions  that require the Company to
maintain certain financial ratios as well as restrictions on the payment of cash
dividends.  The initial  maturity  date of the line of credit with Commerce Bank
was March 20, 2004. The term loan required equal monthly  principal  payments of
$187,000 and matures on April 1, 2006.  The mortgage loan requires equal monthly
principal payments of $19,000 and matures on April 1, 2017. The mortgage loan is
callable after five years at the lender's option.

     In November,  2003, the Company's  credit  agreement with Commerce Bank was
amended to modify the interest rate and amortization schedule for certain of the
loans thereunder, as well as to modify one of the financial covenants. Beginning
November 1, 2003,  the revolving  line of credit bore interest at the prime rate
plus 1.5%, with a floor of 5.5%, and the term loan began to accrue interest at a
fixed rate of 7.5%.  Beginning  December 1, 2003,  the term loan requires  equal
monthly  principal  payments of $193,000  plus  interest with a final payment on
April 1, 2006 of all remaining unpaid principal and interest.

     At March 31, 2003, June 30, 2003, September 30, 2003 and December 31, 2003,
the Company was unable to meet one of its financial covenants required under its
credit agreement with Commerce Bank, which non-compliance was waived by the Bank
effective as of each such date.

     In March,  2004,  the  Company's  credit  agreement  with Commerce Bank was
amended to (i) extend the  maturity  date of the line of credit  until  April 1,
2005,  (ii)  reduce the maximum  amount  that may be borrowed  under the line of
credit to $6,000,000,  (iii) suspend the applicability of the cash flow coverage
ratio  covenant  until  March 31,  2005,  (iv) impose a new  financial  covenant
requiring the Company to achieve certain levels of  consolidated  pre-tax income
on a quarterly  basis  commencing  with the fiscal quarter ended March 31, 2004,
and (v) require that the Company make a prepayment  against its outstanding term
loan to the Bank equal to 100% of the amount of any  prepayment  received by the
Company on its  outstanding  note  receivable  from a customer,  up to a maximum
amount of $500,000.

     At December 31, 2004,  the Company was unable to meet one of its  financial
covenants  required  under  its  credit  agreement  with  Commerce  Bank,  which
non-compliance was waived by the Bank effective as of such date.

     In March,  2005,  the  Company's  credit  agreement  with Commerce Bank was
amended  to (i)  extend  the  maturity  date of the line of credit  until  April
1,2006,  (ii) provide for a interest rate on the revolving line of credit of the


                                       16



prime rate plus 2.0%, with a floor of 5.5% (8.0% at June 30, 2005),  (iii) waive
the applicability of consolidated  pre-tax income for the quarter ended December
31,  2004,  (iv)  suspend  the  applicability  of the cash flow  coverage  ratio
covenant until March 31, 2006, and (v) impose a financial covenant requiring the
Company to achieve certain levels of consolidated  pre-tax income on a quarterly
basis commencing with the fiscal quarter ended March 31, 2005.

     At March 31, 2005 and June 30, 2005,  the Company was unable to meet one of
its financial  covenants required under its credit agreement with Commerce Bank,
which  non-compliance  was waived by the Bank  effective  as of such  date.  See
footnote  5 in the  notes  to the  Company's  unaudited  consolidated  financial
statements  contained  in this  Form  10-Q for more  information  regarding  the
non-compliance at March 31, 2005 and June 30, 2005 and the accounting  treatment
of portions of the debt under the credit agreement as non-current.

     At  June  30,  2005,  there  was  $4,461,000,   $1,280,000  and  $2,761,000
outstanding  under the revolving  line of credit,  term loan and mortgage  loan,
respectively.

     The Company has from time to time  experienced  short-term cash requirement
issues.  In 2002, the Company paid  approximately  $1,880,000 in connection with
acquiring its majority interest in BDR Broadband and paying off the Seller Notes
for BDR Broadband.  In addition,  the Company will incur additional  obligations
related to royalties, if any, in connection with its $1,167,000 cash investments
during 2003, in NetLinc and BTT. While the Company's  existing  lender agreed to
allow the Company to fund both the BDR Broadband obligations and the NetLinc/BTT
obligations using its line of credit,  such lender did not agree to increase the
maximum amount available under such line of credit. These expenditures,  coupled
with the March 2004  amendment to the Company's  credit  agreement with Commerce
Bank described above, have reduced the Company's working capital. The Company is
exploring  various  alternatives  to  enhance  its  working  capital,  including
inventory-related  pricing and product reengineering efforts, as well as seeking
alternative financing.  During 2004, BDR Broadband had positive cash flow, which
has continued in 2005. As such,  BDR Broadband is not presently  anticipated  to
adversely impact the Company's working capital.

New Accounting Pronouncements

     In December, 2004, the Financial Accounting Standards Board ("FASB") issued
SFAS No. 123R,  "Share-Based  Payment." This statement is a revision to SFAS No.
123,  "Accounting for Stock-Based  Compensation"  and supersedes APB Opinion No.
25,  "Accounting  for Stock Issued to  Employees."  This  statement  establishes
standards for the accounting for  transactions in which an entity  exchanges its
equity  instruments for goods or services,  primarily focusing on the accounting
for  transactions  in which an entity obtains  employee  services in share-based
payment transactions. Companies will be required to measure the cost of employee
services  received in exchange for an award of equity  instruments  based on the
grant-date fair value of the award (with limited  exceptions).  The cost will be
recognized  over the period  during  which an  employee  is  required to provide
service in exchange for the award,  which requisite  service period will usually
be the vesting  period.  The grant-date fair value of employee share options and
similar instruments will be estimated using option-pricing  models. If an equity
award is modified after the grant date,  incremental  compensation  cost will be
recognized  in an amount  equal to the excess of the fair value of the  modified
award  over  the  fair  value  of the  original  award  immediately  before  the
modification.  SFAS No. 123R will be effective for fiscal years  beginning after
June  15,  2005  and  allows  for  several   alternative   transition   methods.
Accordingly, the Company will adopt SFAS No. 123R in its first quarter of fiscal
2006.  The Company is currently  evaluating  the provisions of SFAS No. 123R and
has not yet  determined  the impact that this Statement will have on its results
of operations or financial position.


                                       17



     In November,  2004,  the FASB issued SFAS No. 151,  "Inventory  Costs",  an
amendment  of  Accounting  Research  Bulletin  No. 43  Chapter  4. SFAS No.  151
clarifies the accounting for abnormal amounts of idle facility expense, freight,
handling  costs and wasted  material.  SFAS No. 151 is effective  for  inventory
costs incurred  during fiscal years  beginning  after June 15, 2005. The Company
does not  believe  adoption  of SFAS No. 151 will have a material  effect on its
consolidated financial position, results of operations or cash flows.

     In December,  2004, the FASB issued FASB Staff Position No. 109-1 ("FSP FAS
No.  109-1"),  "Application  of FASB Statement No. 109,  'Accounting  for Income
Taxes,' to the Tax Deduction on Qualified Production  Activities Provided by the
American  Jobs  Creation  Act of 2004." The American  Jobs  Creation Act of 2004
introduces  a special  tax  deduction  of up to 9% when fully  phased in, of the
lesser of "qualified  production  activities  income" or taxable income. FSP FAS
109-1 clarifies that this tax deduction should be accounted for as a special tax
deduction  in  accordance  with SFAS No.  109.  Although  FSP FAS No.  109-1 was
effective upon issuance,  the Company is still evaluating the impact FSP FAS No.
109-1 will have on its consolidated financial statements.

     In December,  2003, the FASB issued a revision to SFAS No. 132, "Employers'
Disclosures  about Pensions and Other  Postretirement  Benefits." This statement
does not change the  measurement or  recognition  aspects for pensions and other
post-retirement benefit plans; however, it does revise employers' disclosures to
include more information about the plan assets,  obligations to pay benefits and
funding  obligations.  SFAS No. 132,  as revised,  is  generally  effective  for
financial  statements  with a fiscal year ending after  December  15, 2003.  The
Company has adopted the  required  provisions  of SFAS No. 132, as revised.  The
adoption of the required provisions of SFAS No. 132, as revised,  did not have a
material effect on the Company's consolidated financial statements.

     In May,  2003,  the FASB  issued  SFAS No.  150,  "Accounting  for  Certain
Financial Instruments with Characteristics of both Liabilities and Equity." SFAS
No. 150  clarifies the  definition  of a liability as currently  defined in FASB
Concepts  Statement No. 6 "Elements of Financial  Statements,"  as well as other
planned revisions.  This statement requires a financial instrument that embodies
an obligation of an issuer to be  classified  as a liability.  In addition,  the
statement  establishes  standards for the initial and subsequent  measurement of
these  financial  instruments  and  disclosure  requirements.  SFAS  No.  150 is
effective for financial  instruments entered into or modified after May 31, 2003
and for all other  matters,  is effective at the  beginning of the first interim
period  beginning after June 15, 2003. The adoption of SFAS No. 150 did not have
a material effect on the Company's financial position or results of operations.

     In  January,   2003,  the  FASB  issued  Interpretation   ("FIN")  No.  46,
"Consolidation  of Variable  Interest  Entities" and in December 2003, a revised
interpretation  was issued  (FIN No. 46, as  revised).  In  general,  a variable
interest entity ("VIE") is a corporation partnership,  trust, or any other legal
structure used for business  purposes that either does not have equity investors
with  voting  rights or has  equity  investors  that do not  provide  sufficient
financial  resources  for the entity to support its  activities.  FIN No. 46, as
revised  requires  a VIE to be  consolidated  by a company  if that  company  is
designated  as the  primary  beneficiary.  The  interpretation  applies  to VIEs
created after January 31, 2003,  and for all financial  statements  issued after
December 15, 2003 for VIEs in which an enterprise held a variable  interest that
it acquired before February 1, 2003. The adoption of FIN No. 46, as revised, did
not have a material  effect on the  Company's  financial  position or results of
operations.

     In March,  2005, the Financial  Accounting  Standards Board ("FASB") issued
FASB interpretation ("FIN") No. 47, "Accounting for Conditional Asset Retirement
Obligations - An  Interpretation  of FASB  Statement No. 143" ("FIN 47"),  which
will result in (a) more consistent  recognition of liabilities relating to asset
retirement obligations, (b) more information about expected future cash outflows
associated with those obligations,  and (c) more information about investment in
long-lived  assets because  additional asset retirement costs will be recognized
as part of the carrying  amounts of the assets.  FIN 47 clarifies  that the term
conditional asset retirement obligation as used in SFAS No. 143, "Accounting for
Asset Retirement  Obligations," refers to a legal obligation to perform an asset
retirement  activity  in which  the  timing  and/or  method  of  settlement  are
conditional  on a future  event that may or may not be within the control of the
entity. The obligation to perform the asset retirement activity is unconditional
even though  uncertainty  exists about the timing and/or  method of  settlement.
Uncertainty  about the timing and/or method of settlement of a conditional asset
retirement  obligation  should be factored into the measurement of the liability
when sufficient  information  exists. FIN 47 also clarifies when an entity would
have  sufficient  information to reasonably  estimate the fair value of an asset
retirement obligation. FIN 47 is effective no later than the end of fiscal years
ending after  December 15, 2005. The Company plans to adopt FIN 47 at the end of
its 2005 fiscal year and does not believe that the adoption will have a material
impact on its results of operations or financial position.




ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

     The  market  risk  inherent  in the  Company's  financial  instruments  and
positions represents the potential loss arising from adverse changes in interest
rates. At June 30, 2005 and 2004 the principal amount of the Company's aggregate
outstanding   variable  rate   indebtedness   was  $4,461,000  and   $4,926,000,
respectively.  A  hypothetical  100 basis point increase in interest rates would
have had an annualized  unfavorable impact of approximately $45,000 and $49,000,
respectively,  on the  Company's  earnings  and  cash  flows  based  upon  these
quarter-end  debt  levels.  At June  30,  2005,  the  Company  did not  have any
derivative financial instruments.


                                       18






ITEM 4.  CONTROLS AND PROCEDURES

     The Company  carried out an evaluation,  under the supervision and with the
participation  of  its  principal  executive  officer  and  principal  financial
officer,  of the  effectiveness  of the design and  operation  of the  Company's
disclosure  controls and  procedures as of the end of the period covered by this
report. Based on this evaluation,  the Company's principal executive officer and
principal financial officer concluded that the Company's disclosure controls and
procedures  were  effective  in timely  alerting  them to  material  information
required to be included in the  Company's  periodic  SEC  reports.  It should be
noted that the design of any system of  controls  is based in part upon  certain
assumptions about the likelihood of future events, and there can be no assurance
that any design will succeed in achieving  its stated goals under all  potential
future conditions,  regardless of how remote;  however,  the Company's principal
executive  officer and  principal  financial  officer  have  concluded  that the
Company's  disclosure  controls  and  procedures  are  effective at a reasonable
assurance level.

     There have been no changes in the Company's internal control over financial
reporting,  to the extent  that  elements  of internal  control  over  financial
reporting are subsumed  within  disclosure  controls and  procedures,  that have
materially  affected,  or  are  reasonably  likely  to  materially  affect,  the
Company's internal control over financial reporting.





                           PART II - OTHER INFORMATION



ITEM 1.  LEGAL PROCEEDINGS

     The Company is a party to certain  proceedings  incidental  to the ordinary
course of its business, none of which, in the current opinion of management,  is
likely to have a material  adverse effect on the Company's  business,  financial
condition, or results of operations.




ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

         None.




ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

         None.




ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

     The Company held its Annual Meeting of Stockholders  (the "Meeting") on May
24, 2005. The Company solicited  proxies in connection with the Meeting.  At the
record date of the Meeting (March 31, 2005),  there were 7,566,881 shares of the
Company's common stock  outstanding and entitled to vote. The following were the
matters voted upon at the Meeting:

     1.  Election of  Directors.  The  following  directors  were elected at the
Meeting:  John E. Dwight,  Robert E. Heaton and James A.  Luksch.  The number of
votes cast for and withheld from each director are as follows:



  DIRECTORS                          FOR                        WITHHELD
  John E. Dwight                     6,120,435                  322,436
  Robert E. Heaton                   6,160,676                  282,195
  James A. Luksch                    6,134,535                  308,336


Robert B. Mayer,  James F.  Williams,  Robert J.  Palle,  Jr.,  Gary  Scharmett,
Stephen K.  Necessary and James H.  Williams,  continued as directors  after the
meeting.


                                       19



     2. Approval of the 2005 Employee Equity  Incentive Plan. The Company's 2005
Employee Equity  Incentive Plan was approved by the following vote of the common
stock:

         FOR                      AGAINST                    ABSTAIN
     3,676,654                   995,408                     8,050

     3. Approval of the 2005 Director Equity  Incentive Plan. The Company's 2005
Director Equity  Incentive Plan was approved by the following vote of the common
stock:

         FOR                      AGAINST                    ABSTAIN
     3,666,704                  1,006,808                    6,600

     4.  Ratification of Auditors.  The  appointment of BDO Seidman,  LLP as the
Company's  independent  registered  public accountant for the fiscal year ending
December 31, 2005 was ratified by the following vote of common stock:

         FOR                      AGAINST                    ABSTAIN
     6,388,691                    43,080                     11,100





ITEM 5.  OTHER INFORMATION

         None.




ITEM 6.  EXHIBITS

         Exhibits

     The exhibits are listed in the Exhibit Index appearing at page 22 herein.


                                       20







                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.

                                               BLONDER TONGUE LABORATORIES, INC.



         Date:  August 15, 2005        By:    /s/  James A. Luksch
                                              James A. Luksch
                                              Chief Executive Officer



                                       By:     /s/  Eric Skolnik
                                               Eric Skolnik
                                               Senior Vice President
                                               and Chief Financial Officer
                                               (Principal Financial Officer)



                                       21






                                  EXHIBIT INDEX






Exhibit #      Description                          Location

3.1     Restated Certificate of       Incorporated by reference from Exhibit 3.1
        Incorporation of Blonder      to S-1 Registration Statement No. 33-98070
        Tongue Laboratories, Inc.     originally filed October 12,1995, as amended.


3.2     Restated Bylaws of Blonder    Incorporated by reference from Exhibit
        Tongue Laboratories, Inc.     3.2 to S-1 Registration Statement No.
                                      33-98070 originally filed October 12,
                                      1995, as amended.

10.1    Blonder Tongue Laboratories,  Incorporated by reference from Appendix A
        Inc. 2005 Employee Equity     to the Company's Definitive Proxy
        Incentive Plan.               Statement for its 2005 Annual Meeting of
                                      Stockholders held on May 24, 2005.

10.2    Blonder Tongue Laboratories,  Incorporated by reference from Appendix B
        Inc. 2005 Director Equity     to the Company's Definitive Proxy
        Incentive Plan.               Statement for its 2005 Annual Meeting of
                                      Stockholders held on May 24, 2005.

10.3    Form of Option Agreement for  Filed herewith.
        2005 Employee Equity
        Incentive Plan.

31.1    Certification of James A.     Filed herewith.
        Luksch pursuant to Section
        302 of the Sarbanes-Oxley Act
        of 2002.

31.2    Certification of Eric         Filed herewith.
        Skolnik pursuant to Section
        302 of the Sarbanes-Oxley
        Act of 2002.

32.1    Certification pursuant to     Filed herewith.
        Section 906 of Sarbanes-
        Oxley Act of 2002.



                                22





                                                                    Exhibit 10.3


                        BLONDER TONGUE LABORATORIES, INC.
                       2005 EMPLOYEE EQUITY INCENTIVE PLAN
                        INCENTIVE STOCK OPTION AGREEMENT

     THIS  AGREEMENT  is made  and  entered  into as of  this  _________  day of
__________________,  2005, by and between  BLONDER TONGUE  LABORATORIES,  INC. a
Delaware  corporation  (the  "Company"),  and  __________________  ("Optionee").
Background

     The Optionee is a key employee of the Company's  and  possesses  knowledge,
experience and skill necessary for the Company's future growth and success.  The
Company has adopted the Blonder Tongue  Laboratories,  Inc. 2005 Employee Equity
Incentive  Plan (the "Plan").  Pursuant to and in accordance  with the Plan, the
Company desires to grant to the Optionee an incentive stock option as defined in
Section 422 of the Internal Revenue Code of 1986, as amended, to purchase shares
of the Company's Common Stock as more fully set forth below.  Capitalized  terms
used in this Agreement and not otherwise defined herein, shall have the meanings
ascribed to them in the Plan.

     NOW,  THEREFORE,  in  consideration  of  the  premises  and  the  covenants
contained herein, and intending to be legally bound, it is agreed as follows:

     1. Option to Purchase Shares.  The Company hereby grants to the Optionee an
Option (the "Option"),  pursuant to the Plan, but subject to the Plan's approval
by the stockholders of the Company within 12 months of the adoption of the Plan,
to purchase up to  ______________________________________________  shares of the
Company's  Common Stock (the "Stock").  The Option Price for each share of Stock
shall be  ________________________________________,  which is acknowledged to be
at least 100% of the Fair  Market  Value  (defined in the Plan) of each share of
Stock as of the date hereof (or at least 110% of such Fair  Market  Value if the
Optionee owns, or is deemed to own pursuant to Section 424(d) of the Code,  more
than 10% of the  total  combined  voting  power of all  classes  of stock of the
Company).  The Option shall be exercisable for the number of shares of Stock and
during the specific  exercise  periods  ("Exercise  Period(s)") set forth in the
following table:

         Number of Shares                                     Exercise Period

       ___________________                           ___________________________

     2. Manner of Exercise and Terms of Payment.  The Option may be exercised in
whole or in part,  subject to the limitations set forth in this Agreement,  upon
delivery to the Company of timely  written  notice of exercise,  accompanied  by
full  payment of the Option  Price for the shares of Stock with respect to which
the Option is  exercised.  Full payment shall be in cash or, if and as permitted
by the Committee in its sole discretion: (i) by the Optionee's note payable over
such  period  of  time,  at such  rate of  interest  and in form  and  substance
satisfactory to the Committee;  (ii) by tendering stock of the Company; or (iii)
by withholding stock subject to the Option, all as provided in the Plan.

     3. Termination of Option.

          (a) Expiration or Termination  of Employment.  Except as  specifically
     provided in Section  3(b) and 3(c)  hereof,  the Option  granted  hereunder
     shall terminate as of the close of business on the earliest to occur of the
     date of (i) expiration of the Exercise Period,  (ii) an event of default or
     breach by the Optionee of the terms and  conditions of this  Agreement,  or
     (iii) termination of the Optionee's  employment with the Company for cause.
     If the Optionee's  employment is terminated other than for cause, death (as
     provided in subsection  (b) below),  or  retirement or disability  (both as
     provided in subsection  (c) below),  the Optionee must exercise his Option,
     if at all and to the extent then exercisable,  within 30 days from the date
     of such  termination,  in  accordance  with the  terms of the Plan and this
     Agreement.

          (b) Death of Optionee.  If the Optionee  dies prior to the exercise of
     the  Option  in  full,  the  Option  may be  exercised  by  the  Optionee's
     executors,  administrators  or heirs  within one year after the date of the
     Optionee's death,  provided death occurred during the Optionee's employment
     with the Company,  or within three months  following the termination of the
     Optionee's  employment  with  the  Company,  by  reason  of the  Optionee's
     retirement after reaching the age of 65 years or the Optionee's  retirement
     after becoming permanently disabled. Such Option may be so exercised by the
     Optionee's  executors,  administrators  or heirs only with  respect to that
     number of shares of Stock which the  Optionee had an Option to purchase and
     only to the extent that the Option was exercisable (but had not theretofore
     been  exercised) as of the date of the earlier of the (i) retirement of the
     Optionee after  reaching the age of 65 years or after becoming  permanently
     disabled,  or (ii)  death of the  Optionee.  In no event may the  Option be
     exercised at any time after the expiration of the Exercise Period stated in
     Section 1 hereof.

          (c) Retirement or Disability.  If the Optionee's  employment  with the
     Company is  terminated,  prior to the  exercise  of the Option in full,  by
     reason of the Optionee's  retirement  after reaching the age of 65 years or
     by reason of the Optionee's retirement after becoming permanently disabled,
     the Optionee  shall have the right,  during the period  ending three months
     after the date of the Optionee's termination of employment, to exercise the
     Option to the extent that it was  exercisable but not exercised at the date
     of the Optionee's  termination of employment with the Company.  Such Option
     may be so  exercised  by the  Optionee  only with respect to that number of
     shares of Stock which the  Optionee  had an Option to purchase  and only to
     the extent that the Option was exercisable  (but had not  theretofore  been
     exercised) as of the date that the Optionee  retires after reaching the age
     of 65 years or after  becoming  permanently  disabled.  In no event may the
     Option be exercised at any time after the expiration of the Exercise Period
     stated in Section 1 hereof.

     4. Rights as Shareholder.  An Optionee or permitted transferee of an Option
shall have no rights as a shareholder  of the Company with respect to any shares
of Stock subject to such Option prior to the Optionee's  purchase of such shares
of Stock by exercise of such Option as provided in the Plan.

     5.  Delivery of Stock  Certificates.  The Company  shall not be required to
issue or deliver any certificate for shares of Stock purchased upon the exercise
of  all or any  portion  of an  Option  granted  under  the  Plan  prior  to the
fulfillment of any of the following  conditions which may, from time to time, be
applicable to the issuance of the Stock:

          (a)  Listing  of  Shares.  The  admission  of such  shares of Stock to
     listing on all stock  exchanges  on which the Stock of the  Company is then
     listed.

          (b) Registration and/or Qualification of Shares. The completion of any
     registration  or other  qualification  of such  shares  of Stock  under any
     federal or state  securities laws or under the  regulations  promulgated by
     the  Securities  and  Exchange  Commission  or any other  federal  or state
     governmental  regulatory body which the Board or Committee, as the case may
     be,  deems  necessary  or  advisable.  The  Company  shall  in no  event be
     obligated to register any securities pursuant to the Securities Act of 1933
     (as now in effect or as  hereafter  amended) or to take any other action in
     order to cause the  issuance and  delivery of such  certificates  to comply
     with any such law, regulations or requirement.

          (c) Approval or Clearance.  The obtaining of any approval or clearance
     from any federal or state governmental agency which the Board or Committee,
     as the case may be, shall determine to be necessary or advisable.

          (d) Reasonable  Lapse of Time. The lapse of such reasonable  period of
     time following the exercise of the Option as the Board or Committee, as the
     case may be, may establish from time to time for reasons of  administrative
     convenience.

     6. (a) Anti-Dilution. Except as otherwise expressly provided herein, if the
outstanding  shares of Common Stock are hereafter  changed or converted into, or
exchanged  or  exchangeable  for, a different  number or kind of shares or other
securities   of  the  Company  or  of  another   corporation   by  reason  of  a
reorganization,  merger,  consolidation,  recapitalization,  reclassification or
combination  of shares,  stock  dividend  stock  split or reverse  stock  split,
appropriate  adjustment shall be made by the Board of Directors in the number of
shares and kind of stock subject to unexercised stock options hereunder,  to the
end that the  proportionate  interest of the  Optionee  shall be  maintained  as
before the occurrence of such event.

          (b)  Non-survival  of  Company.  In  the  event  of a  dissolution  or
     liquidation  of the  Company  or any  merger  or  combination  in which the
     Company is not a surviving  corporation,  each  outstanding  Option granted
     hereunder  shall  terminate,   but  the  Optionee  shall  have  the  right,
     immediately prior to such liquidation,  dissolution, merger or combination,
     to exercise the Option, in whole or in part, to the extent that such Option
     is  then  otherwise  exercisable  and has not  previously  been  exercised,
     provided,  however,  that no adjustment shall be made to an incentive stock
     option which would constitute a "modification" of such Option, as such term
     is defined in Section 424(h)(3) of the Code.

          (c) Change in Control.  In the event of any  contemplated  transaction
     which may  constitute  a change in  control  of the  Company,  the Board of
     Directors may modify the Option granted hereunder, so as to accelerate,  as
     a consequence of or in connection with such transaction, the vesting of the
     Optionee's  right to exercise  such Option.  For this  purpose,  "change in
     control of the  Company"  means a change in control of such  nature that it
     would be required to be reported to the Securities and Exchange  Commission
     pursuant to  Schedule  14A of  Regulation  14A or any  successor  provision
     (whether   or  not  the   Company  is  then   subject  to  such   reporting
     requirements).  A change of control will be deemed to have  occurred if any
     person,  other than  persons  or  entities  who on the date  hereof are the
     "beneficial  owners" (as determined pursuant to Sections 13(d) and 14(d) of
     the Securities Exchange Act of 1934), directly or indirectly, of securities
     of the Company representing 10% or more of the combined voting power of the
     Company's then outstanding securities, is or becomes the "beneficial owner"
     of 25% or more of the combined voting power of the  outstanding  securities
     of the Company or if during two consecutive year periods,  the directors at
     the  beginning  of such  periods  cease for any reason  during the two-year
     period to constitute a majority of the Board of Directors of the Company.

     7. Tax  Attributes.  The incentive  stock option  granted  pursuant to this
Agreement  is  intended  to  qualify  under  Section  422 of the  Code  and  any
provisions  hereof which would prevent such Options from  qualifying are invalid
and of no effect, except as provided in Section 7.2(b) of the Plan. The Optionee
will promptly give written notice to the Company of any sale, exchange, gift, or
other  transaction  of any shares of Stock  acquired  pursuant to such incentive
stock option  which occurs  within two years of the date of grant of such Option
or within one year after the issuance of any shares of Stock pursuant thereto.

     8. Agreement  Subject to Plan. No term or condition of this Agreement shall
be construed or interpreted in a manner  contrary to the purposes and provisions
of the Plan, a copy of which may be obtained  from the Secretary of the Company.
Any question of interpretation arising under the Plan or this Agreement shall be
resolved by the Committee.

     9. Restrictions on Transfers. No Option granted pursuant to the Plan may be
transferred  by an Optionee.  Subject to the  provisions of Section 3(b) hereto,
the Option shall be exercisable only by an Optionee during his lifetime.

     10. Miscellaneous.

          (a) The  Company  reserves  the right to  terminate  at any  time,  by
     written notice to the Optionee, any or all of the restrictions on the Stock
     set forth in this Agreement.  Such termination  shall be effective upon the
     Optionee's receipt of such notice.

          (b) All notices provided for or contemplated herein shall be addressed
     as follows:








   If to the Company:        Blonder Tongue Laboratories, Inc.
                             One Jake Brown Road
                             Old Bridge, New Jersey 08857
                             Attn.:   Chairman of Compensation Committee

   If to the Optionee:       __________________

                             __________________


or to such other addresses as the parties may specify in writing.

          (c)  Whenever  Federal,  state and local tax is due on the exercise of
     Options granted under this Agreement,  the Company may require the Optionee
     or Participant to remit an amount sufficient to satisfy Federal,  state and
     local  withholding  taxes prior to the delivery of any certificate for such
     shares or the lapse of restrictions.

          (d) This  Agreement  does not confer upon or give to the  Optionee any
     right to continued employment by the Company and does not in any way affect
     the right of the Company to  terminate  the  Optionee's  employment  at any
     time.

          (e) This Agreement  shall be construed in accordance  with the laws of
     the State of Delaware.

     IN WITNESS  WHEREOF,  the  undersigned  have executed,  or have caused this
Agreement to be executed, as of the day and year first above written.





BLONDER TONGUE LABORATORIES, INC.                    OPTIONEE


By:_____________________________________      __________________________________
   James A. Luksch, Chief Executive Officer

                                                                    Exhibit 31.1



                                  CERTIFICATION

     I, James A. Luksch, Chief Executive Officer of Blonder Tongue Laboratories,
Inc., certify that:

     1. I have reviewed  this  quarterly  report on Form 10-Q of Blonder  Tongue
Laboratories, Inc.;

     2. Based on my knowledge, this report does not contain any untrue statement
of a  material  fact or omit to  state a  material  fact  necessary  to make the
statements made, in light of the circumstances  under which such statements were
made, not misleading with respect to the period covered by this report;

     3. Based on my knowledge,  the financial  statements,  and other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

     4. The registrant's  other certifying  officer(s) and I are responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

     a)  Designed  such  disclosure  controls  and  procedures,  or caused  such
disclosure  controls and  procedures to be designed  under our  supervision,  to
ensure that  material  information  relating to the  registrant,  including  its
consolidated subsidiaries,  is made known to us by others within those entities,
particularly during the period in which this quarterly report is being prepared;

     b) Evaluated the effectiveness of the registrant's  disclosure controls and
procedures and presented in this report our conclusions  about the effectiveness
of the disclosure  controls and procedures,  as of the end of the period covered
by this report based on such evaluation; and

     c) Disclosed in this report any change in the registrant's internal control
over  financial  reporting  that occurred  during the  registrant's  most recent
fiscal quarter (the registrant's  fourth fiscal quarter in the case of an annual
report) that has  materially  affected,  or is  reasonably  likely to materially
affect, the registrant's internal control over financial reporting; and

     5. The registrant's other certifying officer(s) and I have disclosed, based
on our most recent evaluation of internal control over financial  reporting,  to
the registrant's  auditors and the audit committee of the registrant's  board of
directors (or persons performing the equivalent functions):

          a) All significant  deficiencies and material weaknesses in the design
     or  operation  of  internal  control  over  financial  reporting  which are
     reasonably  likely to adversely affect the registrant's  ability to record,
     process, summarize and report financial information; and

          b) Any fraud,  whether or not material,  that  involves  management or
     other employees who have a significant  role in the  registrant's  internal
     control over financial reporting.


Date:  August 15, 2005

                                                    /s/  James A. Luksch
                                                   James A. Luksch
                                                   Chief Executive Officer
                                                   (Principal Executive Officer)





                                                                    Exhibit 31.2



                                  CERTIFICATION

          I, Eric Skolnik,  Senior Vice President and Chief Financial Officer of
     Blonder Tongue Laboratories, Inc., certify that:

          1. I have  reviewed  this  quarterly  report on Form  10-Q of  Blonder
     Tongue Laboratories, Inc.;

          2. Based on my  knowledge,  this  report  does not  contain any untrue
     statement of a material fact or omit to state a material fact  necessary to
     make the statements  made, in light of the  circumstances  under which such
     statements  were made, not misleading with respect to the period covered by
     this report;

          3.  Based  on  my  knowledge,  the  financial  statements,  and  other
     financial  information  included  in this  report,  fairly  present  in all
     material respects the financial  condition,  results of operations and cash
     flows of the  registrant  as of, and for,  the  periods  presented  in this
     report;

          4. The registrant's other certifying  officer(s) and I are responsible
     for  establishing  and maintaining  disclosure  controls and procedures (as
     defined in Exchange Act Rules  13a-15(e) and  15d-15(e)) for the registrant
     and have:

               a) Designed such disclosure  controls and  procedures,  or caused
          such  disclosure  controls  and  procedures  to be designed  under our
          supervision,  to ensure  that  material  information  relating  to the
          registrant,  including its consolidated subsidiaries, is made known to
          us by others within those entities,  particularly during the period in
          which this quarterly report is being prepared;

               b) Evaluated the  effectiveness  of the  registrant's  disclosure
          controls and procedures  and presented in this report our  conclusions
          about the effectiveness of the disclosure controls and procedures,  as
          of the  end of the  period  covered  by  this  report  based  on  such
          evaluation; and

               c)  Disclosed  in this  report  any  change  in the  registrant's
          internal  control over financial  reporting  that occurred  during the
          registrant's  most recent  fiscal  quarter  (the  registrant's  fourth
          fiscal  quarter in the case of an annual  report) that has  materially
          affected,   or  is  reasonably  likely  to  materially   affect,   the
          registrant's internal control over financial reporting; and

          5. The registrant's other certifying  officer(s) and I have disclosed,
     based on our most recent  evaluation  of internal  control  over  financial
     reporting,  to the  registrant's  auditors  and the audit  committee of the
     registrant's  board of  directors  (or persons  performing  the  equivalent
     functions):

               a) All significant  deficiencies  and material  weaknesses in the
          design or operation of internal control over financial reporting which
          are reasonably likely to adversely affect the registrant's  ability to
          record, process, summarize and report financial information; and

               b) Any fraud,  whether or not material,  that involves management
          or other  employees  who have a significant  role in the  registrant's
          internal control over financial reporting.



Date:  August 15, 2005


                                            /s/  Eric Skolnik
                                            Eric Skolnik
                                            Senior Vice President and Chief
                                            Financial Officer (Principal
                                            Financial Officer)
                                                                   Exhibit 32.1







                                  CERTIFICATION
            PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     To the knowledge of each of the  undersigned,  this Report on Form 10-Q for
the quarter ended June 30, 2005 fully complies with the  requirements of Section
13(a) or 15(d) of the  Securities  Exchange  Act of 1934,  as  amended,  and the
information  contained in this Report fairly presents, in all material respects,
the  financial   condition   and  results  of   operations  of  Blonder   Tongue
Laboratories, Inc. for the applicable reporting period.


Date:  August 15, 2005       By:      /s/  James A. Luksch
                                      James A. Luksch, Chief Executive Officer



                             By:      /s/  Eric Skolnik
                                      Eric Skolnik, Chief Financial Officer